Literature DB >> 14532325

Fragile X Mental Retardation protein determinants required for its association with polyribosomal mRNPs.

Rachid Mazroui1, Marc-Etienne Huot, Sandra Tremblay, Nathalie Boilard, Yves Labelle, Edouard W Khandjian.   

Abstract

Fragile X Mental Retardation protein (FMRP) is an RNA-binding protein that contains multiple domains with apparently differential affinity to mRNA and to the ribonucleotide homopolymer poly(G). Attempts have been made to map the RNA-binding sites along the protein sequence with a view to determining which of the KH1, KH2 and RGG domains are required to recognize and bind to RNA. While these studies have greatly contributed to the delineation of domains that bind homopolymers or mRNA in vitro, little is known concerning their implications in FMRP function(s) in vivo. To address this question, we have prepared a series of FMRP versions, in which each known in vitro functional domain has been individually deleted, leaving the rest of the protein intact. Constructs with deletions in the protein-protein interaction and RNA-binding as well as in the phosphorylation domains were expressed in STEK-KO cells lacking FMRP and their recruitment into polyribosomal mRNPs and their intra-cellular localization were determined. Our results indicate that the KH RNA-binding domains and the Protein-Protein Interacting domain are essential for FMRP to associate with polyribosomal mRNPs, while the RGG box and the phosphorylated domains are dispensable.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14532325     DOI: 10.1093/hmg/ddg335

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  40 in total

1.  Analysis of translation initiation during stress conditions by polysome profiling.

Authors:  Laëtitia Coudert; Pauline Adjibade; Rachid Mazroui
Journal:  J Vis Exp       Date:  2014-05-19       Impact factor: 1.355

2.  Substitution of critical isoleucines in the KH domains of Drosophila fragile X protein results in partial loss-of-function phenotypes.

Authors:  Paromita Banerjee; Shweta Nayar; Sarita Hebbar; Catherine F Fox; Michele C Jacobs; Jae H Park; Joyce J Fernandes; Thomas C Dockendorff
Journal:  Genetics       Date:  2006-12-28       Impact factor: 4.562

3.  A new regulatory function of the region proximal to the RGG box in the fragile X mental retardation protein.

Authors:  Ernest Blackwell; Stephanie Ceman
Journal:  J Cell Sci       Date:  2011-08-24       Impact factor: 5.285

4.  RNA-Binding Specificity of the Human Fragile X Mental Retardation Protein.

Authors:  Youssi M Athar; Simpson Joseph
Journal:  J Mol Biol       Date:  2020-04-25       Impact factor: 5.469

5.  Recombinant bacterial expression and purification of human fragile X mental retardation protein isoform 1.

Authors:  Timothy L Evans; Mihaela-Rita Mihailescu
Journal:  Protein Expr Purif       Date:  2010-06-10       Impact factor: 1.650

6.  Inhibition of the ubiquitin-proteasome system induces stress granule formation.

Authors:  Rachid Mazroui; Sergio Di Marco; Randal J Kaufman; Imed-Eddine Gallouzi
Journal:  Mol Biol Cell       Date:  2007-05-02       Impact factor: 4.138

7.  Biochemical evidence for the association of fragile X mental retardation protein with brain polyribosomal ribonucleoparticles.

Authors:  Edouard W Khandjian; Marc-Etienne Huot; Sandra Tremblay; Laetitia Davidovic; Rachid Mazroui; Barbara Bardoni
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-25       Impact factor: 11.205

8.  Fragile X mental retardation protein regulates translation by binding directly to the ribosome.

Authors:  Eileen Chen; Manjuli R Sharma; Xinying Shi; Rajendra K Agrawal; Simpson Joseph
Journal:  Mol Cell       Date:  2014-04-17       Impact factor: 17.970

9.  Discrimination of common and unique RNA-binding activities among Fragile X mental retardation protein paralogs.

Authors:  Jennifer C Darnell; Claire E Fraser; Olga Mostovetsky; Robert B Darnell
Journal:  Hum Mol Genet       Date:  2009-06-01       Impact factor: 6.150

10.  A mouse model of the human Fragile X syndrome I304N mutation.

Authors:  Julie B Zang; Elena D Nosyreva; Corinne M Spencer; Lenora J Volk; Kiran Musunuru; Ru Zhong; Elizabeth F Stone; Lisa A Yuva-Paylor; Kimberly M Huber; Richard Paylor; Jennifer C Darnell; Robert B Darnell
Journal:  PLoS Genet       Date:  2009-12-11       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.